Healthcare - Biotechnology - NASDAQ - US
$ 0.1
-9.09 %
$ 1.09 M
Market Cap
-0.04
P/E
INCOME STATEMENT
0
REVENUE
-16.1 M
OPERATING INCOME
-18.3 M
NET INCOME
EFFICIENCY
Earnings Waterfall
PaxMedica, Inc. Common Stock
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 16.1 M |
| Operating Income | -16.1 M |
| Other Expenses | 2.14 M |
| Net Income | -18.3 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 16.1 | 10.6 | 7.2 | 5.6 | 0.6 |
| Selling, General and Administrative Expenses | 12.2 | 8.8 | 5.0 | 4.6 | 0.1 |
| Research and Development Expenses | 3.9 | 1.8 | 2.2 | 0.9 | 0.5 |
| Operating Income | (16.1) | (10.6) | (7.2) | (5.6) | (0.6) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 9.16 K | 5.24 K | 2.8 | 0.6 | 0 |
| Total Other Income | (2.1) | (4.2) | (3.0) | (2.3) | 0 |
| Pre-Tax Income | (18.3) | (14.8) | (10.2) | (7.8) | (0.6) |
| NET INCOME | |||||
| Tax Provision | (0.2) | 4.2 | 2.8 | 0.7 | (0.2) |
| Net Income | (18.3) | (14.8) | (13.0) | (8.5) | (0.6) |
| EPS | 11 | 28.8 | 18.8 | 12.2 | 0.0598 |